Source comparison
5-Amino-1MQ MOTS-C Metabolic Stack: Protocol Comparison
Fat Oxidation Focus 50–75mg daily 10mg daily 5-Amino-1MQ oral; MOTS-C subcutaneous Maximize adipocyte NAD+ and AMPK-driven lipolysis Best for body composition studies. Both compounds dose-dependently increase fat oxidation Insulin Sensitivity Focus 30–50mg dai
This comparison does not assign a generated winner or score.
- Fat Oxidation Focus
- 50–75mg daily
- 10mg daily
- 5-Amino-1MQ oral; MOTS-C subcutaneous
- Maximize adipocyte NAD+ and AMPK-driven lipolysis
- Best for body composition studies. Both compounds dose-dependently increase fat oxidation
- Insulin Sensitivity Focus
- 30–50mg daily
- 15mg daily
- Both compounds daily
- Improve glucose disposal and reduce hepatic glucose output
- Best for metabolic syndrome models. MOTS-C dose correlates with GLUT4 translocation
- Endurance/Mitochondrial Focus
- 50mg daily
- 10–15mg daily
- 5-Amino-1MQ oral; MOTS-C pre-activity
- Increase mitochondrial biogenesis and exercise capacity
- Best for performance research. MOTS-C enhances running endurance by 30% in published trials
- Longevity/NAD+ Restoration
- 75–100mg daily
- 5–10mg daily
- 5-Amino-1MQ oral; MOTS-C 3–5x weekly
- Restore declining NAD+ and mitochondrial signaling with age
- Best for aging research. Both compounds decline endogenously with age